Methotrexate Intraocular Recall Due to Sterility Assurance Concerns
Natures Pharmacy & Compounding Center is recalling all unexpired lots of Methotrexate Intraocular 400mcg 0.1cc due to quality control issues affecting sterility assurance.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classified this as an FDA Class II recall. The hazard involves a lack of sterility assurance in a sterile injectable product, which poses a significant risk of serious injury or infection, fitting the 'Severe' criteria for significant injury reports or high-risk structural/quality defects.
Plain-English summary
Natures Pharmacy & Compounding Center is recalling all unexpired lots of Methotrexate Intraocular 400mcg 0.1cc. The recall is limited to the state of North Carolina (NC).
The recall was initiated due to concerns regarding quality control procedures that present a potential risk to sterility assurance. These concerns were observed during a recent FDA inspection of the pharmacy's sterile compounding processes.
Consumers who have this product should stop using it and contact their healthcare provider or the pharmacy for further instructions.
The recalled product
- Product
- Methotrexate Intraocular 400mcg 0.1cc
- Manufacturer
- Natures Pharmacy & Compounding Center
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lot numbers within expiry.
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 48 recalled by Natures Pharmacy & Compounding Center under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 48 products in this recall →Related recalls
Same manufacturer · Natures Pharmacy & Compounding Center
See all →- SevereNatures Pharmacy Recalls Triamcinolone Acetonide Due to Sterility Concerns
FDA (Drugs) · 2014-03-12
- SevereSodium Bicarbonate Injection Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2014-03-12
- SevereFDA Recalls Estradiol and Testosterone Compounds for Sterility Concerns
FDA (Drugs) · 2014-03-12
- SevereNatures Pharmacy Recalls Glutathione Inhalation Due to Sterility Concerns
FDA (Drugs) · 2014-03-12
- SevereNatures Pharmacy Recalls Voriconazole Due to Sterility Assurance Concerns
FDA (Drugs) · 2014-03-12
Same hazard · sterility assurance
See all →- HighArrowhead DE LLC Recalls Arrow-LOK Implants Due to Sterility Assurance Concerns
FDA (Devices) · 2026-08-26
- SevereChloraPrep One-Step Applicators Recalled for Potential Packaging Seal Defects
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15
- SevereChloraPrep One-Step Applicators Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2026-07-08
- SevereArrow access trays and PSI kits contain recalled supplier drugs
FDA (Devices) · 2026-06-24
Similar recalls
- SevereMethotrexate Injectable Recalled Due to Sterility Concerns
FDA (Drugs) · 2013-06-12
- HighMethotrexate Injectable Vials Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2023-02-01
- SevereClinical Specialties Compounding Pharmacy Recalls Medroxyprogesterone Due to Sterility Concerns
FDA (Drugs) · 2013-07-10
- SevereMedical Center Pharmacy Recalls Mitomycin Eye Drops Due to Sterility Concerns
FDA (Drugs) · 2020-04-08
- SevereProgesterone Injection Recalled Due to Sterility Concerns
FDA (Drugs) · 2013-07-10
- HighHealth Innovations Pharmacy Recalls Naltrexone Capsules Due to Sterility Concerns
FDA (Drugs) · 2015-05-20